Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model

doi:10.3748/wjg.v13.i17.2484

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2000)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

293

HTML

1372

Figures (1-5)

199

Tables (1-1)

136

Sum=2000

May 7, 2007 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. May 7, 2007; 13(17): 2484-2489
Published online May 7, 2007. doi: 10.3748/wjg.v13.i17.2484

Full Size Figure Download Figure

Figure 4 The combination therapy synergistic inhibition of angiogenesis (A) and proliferation (B), and induction apoptosis (C) at d 31 after tumor cell injection. ¹Synergistic relationship in the combination therapy (synergistic index > 1). ^aP < 0.05 vs untreated group.

Citation: Zheng SJ, Zheng SP, Huang FY, Jiao CL, Wu RL. Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model. World J Gastroenterol 2007; 13(17): 2484-2489
URL: https://www.wjgnet.com/1007-9327/full/v13/i17/2484.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i17.2484